168 related articles for article (PubMed ID: 36752584)
1. Prolactin in headache and migraine: A systematic review of preclinical studies.
Al-Karagholi MA; Kalatharan V; Ghanizada H; Dussor G; Ashina M
Headache; 2023 May; 63(5):577-584. PubMed ID: 36752584
[TBL] [Abstract][Full Text] [Related]
2. Prolactin in headache and migraine: A systematic review of clinical studies.
Al-Karagholi MA; Kalatharan V; Ghanizada H; Gram C; Dussor G; Ashina M
Cephalalgia; 2023 Feb; 43(2):3331024221136286. PubMed ID: 36718026
[TBL] [Abstract][Full Text] [Related]
3. Meningeal CGRP-Prolactin Interaction Evokes Female-Specific Migraine Behavior.
Avona A; Mason BN; Burgos-Vega C; Hovhannisyan AH; Belugin SN; Mecklenburg J; Goffin V; Wajahat N; Price TJ; Akopian AN; Dussor G
Ann Neurol; 2021 Jun; 89(6):1129-1144. PubMed ID: 33749851
[TBL] [Abstract][Full Text] [Related]
4. Female-selective mechanisms promoting migraine.
Singh S; Kopruszinski CM; Watanabe M; Dodick DW; Navratilova E; Porreca F
J Headache Pain; 2024 Apr; 25(1):63. PubMed ID: 38658853
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
6. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
7. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
8. Migraine headache pathophysiology.
Andreou AP; Pereira AD
Handb Clin Neurol; 2023; 198():61-69. PubMed ID: 38043971
[TBL] [Abstract][Full Text] [Related]
9. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.
Avona A; Burgos-Vega C; Burton MD; Akopian AN; Price TJ; Dussor G
J Neurosci; 2019 May; 39(22):4323-4331. PubMed ID: 30962278
[TBL] [Abstract][Full Text] [Related]
10. Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine.
Mason BN; Kallianpur R; Price TJ; Akopian AN; Dussor GO
Headache; 2022 Jan; 62(1):11-25. PubMed ID: 34967003
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies.
Thuraiaiyah J; Kokoti L; Al-Karagholi MA; Ashina M
J Headache Pain; 2022 Apr; 23(1):43. PubMed ID: 35382738
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.
Watanabe M; Kopruszinski CM; Moutal A; Ikegami D; Khanna R; Chen Y; Ross S; Mackenzie K; Stratton J; Dodick DW; Navratilova E; Porreca F
Brain; 2022 Aug; 145(8):2894-2909. PubMed ID: 35325034
[TBL] [Abstract][Full Text] [Related]
13. A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
Ikegami D; Navratilova E; Yue X; Moutal A; Kopruszinski CM; Khanna R; Patwardhan A; Dodick DW; Porreca F
Cephalalgia; 2022 Mar; 42(3):197-208. PubMed ID: 34510920
[TBL] [Abstract][Full Text] [Related]
14. Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.
Kilinc E; Dagistan Y; Kukner A; Yilmaz B; Agus S; Soyler G; Tore F
Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):536-546. PubMed ID: 29344989
[TBL] [Abstract][Full Text] [Related]
15. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Meßlinger K
Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to calcitonin gene-related peptide in chronic migraine.
Iljazi A; Ashina H; Zhuang ZA; Lopez Lopez C; Snellman J; Ashina M; Schytz HW
Cephalalgia; 2021 May; 41(6):701-710. PubMed ID: 33322922
[TBL] [Abstract][Full Text] [Related]
18. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G
Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556
[TBL] [Abstract][Full Text] [Related]
19. Interplay of Oral, Mandibular, and Facial Disorders and Migraine.
Teruel A; Romero-Reyes M
Curr Pain Headache Rep; 2022 Jul; 26(7):517-523. PubMed ID: 35567662
[TBL] [Abstract][Full Text] [Related]
20. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
